BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Cipla
McKinsey
Healthtrust
Colorcon
Federal Trade Commission
Chinese Patent Office
Argus Health
Johnson and Johnson
Boehringer Ingelheim

Generated: January 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 071523

« Back to Dashboard

NDA 071523 describes TRAZODONE HYDROCHLORIDE, which is a drug marketed by Accord Hlthcare, Alvogen, Am Therap, Apotex, Apotex Inc, Aurolife Pharma Llc, Mylan, Mylan Pharms Inc, Pliva, Quantum Pharmics, Sandoz, Sun Pharm Industries, Teva, Teva Pharms Usa, Torrent Pharms Ltd, Usl Pharma, Vintage, Watson Labs, and Zydus Pharms Usa Inc, and is included in twenty-eight NDAs. It is available from forty-six suppliers. Additional details are available on the TRAZODONE HYDROCHLORIDE profile page.

The generic ingredient in TRAZODONE HYDROCHLORIDE is trazodone hydrochloride. There are thirteen drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the trazodone hydrochloride profile page.
Summary for 071523
Tradename:TRAZODONE HYDROCHLORIDE
Applicant:Teva Pharms Usa
Ingredient:trazodone hydrochloride
Patents:0
Therapeutic Class:Antidepressants
Formulation / Manufacturing:see details
Pharmacology for NDA: 071523
Suppliers and Packaging for NDA: 071523
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TRAZODONE HYDROCHLORIDE trazodone hydrochloride TABLET;ORAL 071523 ANDA KAISER FOUNDATION HOSPITALS 0179-1118 0179-1118-50 50 TABLET in 1 BOTTLE (0179-1118-50)
TRAZODONE HYDROCHLORIDE trazodone hydrochloride TABLET;ORAL 071523 ANDA KAISER FOUNDATION HOSPITALS 0179-1118 0179-1118-90 90 TABLET in 1 BOTTLE (0179-1118-90)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength50MG
Approval Date:Dec 11, 1987TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
Julphar
McKinsey
Johnson and Johnson
Moodys
AstraZeneca
Chinese Patent Office
UBS
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot